In the context of cardiovascular and cerebrovascular diseases, polymorphisms in the 3′-UTR of the thymidylate synthase (TS) gene may serve as useful biomarkers for predicting and assessing the prognosis of ischemic stroke, silent brain infarction, and coronary artery disease [22,23]. This evidence concerns the gene TYMS and brain infarction.